Study to Evaluate the Safety, Tolerability, and plasma hydroxyproline concentration of load of gelatin in the Healthy Adult Subjects

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1030210178

Enrollment

Registered

2021-07-01

Start date

2021-06-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult Subjects

Interventions

Ingestion of gelatin

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male BMI: 18.5 kg/m2 or more, less than 25.0 kg/m2

Exclusion criteria

Exclusion criteria: Presence of a psychological, gastrointestinal, hepatic, renal, respiratory, endocrine, hematological, immune, neurological, cardiovascular disease or a congenital metabolic abnormality or other anomaly that may affect this study

Design outcomes

Primary

Measure	Time frame
Plasma hydroxyproline concentration Safety endpoints (Adverse events, Laboratory tests, Vital signs)	—

Contacts

Public ContactYutaka Takeuchi

EA Pharma Co., Ltd.

contact_ea@eapharma.co.jp+81-3-6280-9600

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026